Archiv: Novasep (corporation) / vaccine production partner of AstraZeneca corporation


12.02.2021 - 07:15 [ Politico.eu ]

Belgian plant blamed for AstraZeneca vaccine shortage says it met all deliveries

(10.02.2021)

AstraZeneca subcontracted the plant — previously owned by Novasep — to produce the drug substance of its vaccine. Volanti would not say how many doses the plant was contracted to provide. He said the plant sends its drug substance to an Italian company to be put into vials and packaged for distribution.

AstraZeneca declined to comment on Thermo Fisher’s remarks, according to Reuters.

28.01.2021 - 15:37 [ Tagesschau.de ]

Streit über AstraZeneca-Impfstoff: Hoffen auf einen Kompromiss

Die EU sieht das anders: Man habe dem Unternehmen einen Vorschuss gewährt, um auf Halde zu produzieren. Vor der erwarteten Zulassung des Impfstoffs am Freitag durch die Europäische Arzneimittelbehörde hätte AstraZeneca also längst Impfdosen zurückstellen müssen. Stattdessen habe das Unternehmen die für Europa bestimmten Ampullen nach Großbritannien ausgeliefert.

28.01.2021 - 15:31 [ theHindu.com ]

Vaccine factory in Belgium inspected amid European Union dispute with AstraZeneca

The Novasep’s factory in the town of Seneffe is part of the European production chain for the Oxford-AstraZeneca coronavirus vaccine.

28.01.2021 - 15:27 [ .puls24.at ]

Belgien entsendet Ermittler in AstraZenecas Impfstofffabrik

Beamte der belgischen Arzneimittelbehörde statteten dem AstraZeneca-Standort in Seneffe einen Besuch ab. Die EU-Kommission hatte die Untersuchung angefordert. Sie will wissen, ob auf EU-Gebiet produzierte Dosen nach Großbritannien umgeleitet wurden.

26.01.2021 - 12:18 [ Michaela Kuefner, hief Political Editor at DW, Germany's international TV channel / Twitter ]

In an exclusive interview with @dw_politics German health minister @jensspahn calls for a licensing requirement for the export of vaccines outside the EU. Given the state funds spent on building up production capacity this is not about EU “first, but fair” Spahn told me.

26.01.2021 - 11:29 [ Novasep.com ]

Coronavirus: NOVASEP partners with ASTRAZENECA to produce Covid-19 Oxford vaccine for Europe

(15.06.2020)

Novasep brings to AstraZeneca more than 20 years of expertise in viral vector production. Novasep’s investment strategy in the large-scale production of biopharmaceutical products for immunotherapy and gene therapy enables Novasep to support the alliance for the production of the vaccine active substance in Europe.

The production operations will be carried out at Novasep’s Belgian site in Seneffe. Furthermore, the biopharmaceutical ecosystem in the region allows Novasep to rapidly mobilize the additional human resources needed to achieve this project.

26.01.2021 - 10:05 [ Stella Kyriakides, European Commissioner for Health and Food Safety / Twitter ]

With our Member States, we have requested from AZ a detailed planning of vaccine deliveries and when distribution will take place to Member States. Another meeting will be convened on Wednesday to discuss the matter further.

25.01.2021 - 20:25 [ Stella Kyriakides, European Commissioner for Health and Food Safety / Twitter ]

In addition, today we discussed with the 27 Member States in the Steering Board that an export transparency mechanism will be put in place as soon as possible. We want clarity on transactions and full transparency concerning the export of vaccines from the EU.

23.01.2021 - 11:00 [ Stella Kyriakides, European Commissioner for Health and Food Safety / Twitter ]

. @EU_Commission and Member States expressed deep dissatisfaction with this. We insisted on a precise delivery schedule on the basis of which Member States should be planning their vaccination programs, subject to the granting of a contitional marketing authorisation. /2

The @EU_Commission will continue to insist with @AstraZeneca on measures to increase predictability and stability of deliveries, and acceleration of the distribution of doses/3.

23.01.2021 - 10:39 [ Sky.com ]

COVID-19: AstraZeneca to ‚cut COVID-19 vaccine delivery to EU by 60%‘

The company was expected to deliver around 80 million doses to the 27 EU countries by the end of March, an EU official told the agency.

However, it now expects that to be cut to 31 million doses due to „production problems“ at a vaccine factory in Belgium run by its partner Novasep.